http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NO-20054168-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
filingDate 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b092459ace9c8517bb4ff0b33db7677a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_361f27b7d6752073e38a549a5d10ce94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dddc2a7c9ed1f105da5edf44f0358c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6749f572eb0f72601006985ced0cfbd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2a4be9cdf0e3b8d58be7d57444b7ecb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2ad877595e02513de2b8c2add3494ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_164f4be7a8435de808a48527298a4e1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7b5cf170a83c6f49268929c16b544c1
publicationDate 2005-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NO-20054168-L
titleOfInvention Substituted 3- (benzoylureido) thiophene derivatives, process for preparation and use thereof
abstract Compounds of formula I are described in which the residues have the meanings indicated, as well as physiologically acceptable salts thereof. The compounds may be used, for example, as drugs in the prevention and therapy of type 2 diabetes.
priorityDate 2003-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421934249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18445935

Total number of triples: 33.